JP2023509849A5 - - Google Patents

Info

Publication number
JP2023509849A5
JP2023509849A5 JP2022535595A JP2022535595A JP2023509849A5 JP 2023509849 A5 JP2023509849 A5 JP 2023509849A5 JP 2022535595 A JP2022535595 A JP 2022535595A JP 2022535595 A JP2022535595 A JP 2022535595A JP 2023509849 A5 JP2023509849 A5 JP 2023509849A5
Authority
JP
Japan
Prior art keywords
neutrophils
treating cancer
cancer
reference standard
unsuitable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022535595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509849A (ja
Filing date
Publication date
Priority claimed from GBGB1918313.6A external-priority patent/GB201918313D0/en
Application filed filed Critical
Publication of JP2023509849A publication Critical patent/JP2023509849A/ja
Publication of JP2023509849A5 publication Critical patent/JP2023509849A5/ja
Pending legal-status Critical Current

Links

JP2022535595A 2019-12-12 2020-12-11 癌を処置するための細胞 Pending JP2023509849A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1918313.6 2019-12-12
GBGB1918313.6A GB201918313D0 (en) 2019-12-12 2019-12-12 Cells for treating cancer
PCT/GB2020/053199 WO2021116713A1 (en) 2019-12-12 2020-12-11 Cells for treating cancer

Publications (2)

Publication Number Publication Date
JP2023509849A JP2023509849A (ja) 2023-03-10
JP2023509849A5 true JP2023509849A5 (cg-RX-API-DMAC7.html) 2023-12-12

Family

ID=69186690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535595A Pending JP2023509849A (ja) 2019-12-12 2020-12-11 癌を処置するための細胞

Country Status (10)

Country Link
US (1) US20230203441A1 (cg-RX-API-DMAC7.html)
EP (1) EP4073509A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023509849A (cg-RX-API-DMAC7.html)
CN (1) CN115136005A (cg-RX-API-DMAC7.html)
AU (1) AU2020402167A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022011349A2 (cg-RX-API-DMAC7.html)
CA (1) CA3173535A1 (cg-RX-API-DMAC7.html)
GB (1) GB201918313D0 (cg-RX-API-DMAC7.html)
IL (1) IL293740A (cg-RX-API-DMAC7.html)
WO (1) WO2021116713A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201618106D0 (en) 2016-10-26 2016-12-07 Lift Biosciences Ltd Cancer-killing cells
KR20250167646A (ko) 2023-03-10 2025-12-01 리프트 바이오사이언시스 리미티드 치료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
WO2011088402A2 (en) * 2010-01-15 2011-07-21 Memorial Sloan-Kettering Cancer Center The use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients
EP3177315B1 (en) * 2014-08-07 2020-10-07 Reponex Pharmaceuticals A/S Compositions for the treatment of peritonitis

Similar Documents

Publication Publication Date Title
Wang et al. Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA
Maus et al. Human melanoma-derived extracellular vesicles regulate dendritic cell maturation
Schneider et al. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Bakri et al. Balance of MafB and PU. 1 specifies alternative macrophage or dendritic cell fate
Chapellier et al. Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response
FI3835415T3 (fi) Menetelmä cd3-positiivisen solun tuottamiseksi
de Haar et al. Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation
JP7025524B2 (ja) 非動員末梢血を利用した不均一性造血幹細胞・前駆細胞の製造方法
Zhan et al. Single‐cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism‐related mechanisms
Zhang et al. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells
Thinyakul et al. Hippo pathway in cancer cells induces NCAM1+ αSMA+ fibroblasts to modulate tumor microenvironment
Signoretto et al. Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis
Yoshikawa et al. Characterization of CD133+ parenchymal cells in the liver: Histology and culture
Zhang et al. IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/PTGS2 pathway
Chen et al. The core cellular network modulates immune phenotype switching in hepatitis B
Plantinga et al. Cord-blood-stem-cell-derived conventional dendritic cells specifically originate from CD115-expressing precursors
JP2021500081A5 (cg-RX-API-DMAC7.html)
CN104109653A (zh) 利用无动物血清培养体系大规模扩增人外周血dnt细胞的方法
CN119372160A (zh) 源自ido1基因的hla-a*11:01肾细胞癌肿瘤抗原短肽
CN102876632B (zh) 人nk/t细胞系
CN107236709B (zh) 来源于肺转移灶的高转移人卵巢癌细胞系及其建立和应用
Hernandez‐Fernaud et al. Quantitative mass spectrometry‐based proteomics in angiogenesis
Durán et al. Enhanced protocol for CD14+ cell enrichment from equine peripheral blood via anti‐human CD14 mAb and automated magnetic activated cell sorting
CN112451662A (zh) 一种gli蛋白抑制剂及其应用
CN109342383A (zh) Cd90在制备乳腺癌预后诊断的试剂盒和抑癌药物中的应用